Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs ENDRA Life Sciences Inc. (NDRA)

Advanced Biomed Inc. and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $7.5M against $3.1M — 2.4× the size. ENDRA Life Sciences Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.3×. Across the 9 metrics below, Advanced Biomed Inc. leads on 8 and ENDRA Life Sciences Inc. on 1.

Valuation

Metric ADVB NDRA Diagnostics & Research median
P/E 0.33 n/m 34.52
P/S n/m 17.21 4.24
P/B 0.20 0.98 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales n/m 1.88 5.18
Earnings yield 300.76% (127.31%) (1.50%)
Free cash flow yield (185.35%) (127.37%) 0.00%

Profitability

Metric ADVB NDRA Diagnostics & Research median
Gross margin — 0.00% 48.32%
Operating margin 0.00% 0.00% (5.68%)
Net margin 0.00% 0.00% (4.10%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 84.77% (152.04%) 0.00%
Return on assets 36.47% (110.08%) (6.05%)
Return on invested capital (33.43%) (539.89%) 0.00%

Growth

Metric ADVB NDRA Diagnostics & Research median
Revenue growth (TTM) — — 8.99%
EPS growth (last fiscal year) 266.56% 84.32% 20.36%
Revenue growth, 5-year CAGR — — 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB NDRA Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 9.33 7.10 2.27
Net debt to EBITDA 0.06 0.14 0.68

Dividend

Metric ADVB NDRA Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ADVB NDRA Diagnostics & Research median
Market cap 3.14m 7.51m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack